A safety study of perioperative olprinone administration for liver resectio
Phase 1
- Conditions
- Primary liver cancer Metastatic liver cancer
- Registration Number
- JPRN-UMIN000004975
- Lead Sponsor
- Department of Surgery, Graduate School of Medicine, Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
1) Biliary reconstruction 2) Gastrointestinal resection and lymphatic dissection 3) Preoperative percutaneous transhepatic portal embolization 4) Active double cancer 5) Serious complications such as heart or renal failure 6) A history of severe hypersensitivity
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety
- Secondary Outcome Measures
Name Time Method Protective effects on the liver